Merck & Co Inc
6MK
Company Profile
Business description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Contact
126 East Lincoln Avenue
RahwayNJ07065
USAT: +1 908 740-4000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
75,000
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,551.00 | 28.90 | -0.34% |
CAC 40 | 7,886.69 | 33.22 | 0.42% |
DAX 40 | 23,767.43 | 71.84 | 0.30% |
Dow JONES (US) | 42,654.74 | 331.99 | 0.78% |
FTSE 100 | 8,684.56 | 50.81 | 0.59% |
HKSE | 23,126.37 | 218.68 | -0.94% |
NASDAQ | 19,211.10 | 98.78 | 0.52% |
Nikkei 225 | 37,618.81 | 134.91 | -0.36% |
NZX 50 Index | 12,693.37 | 93.42 | -0.73% |
S&P 500 | 5,958.38 | 41.45 | 0.70% |
S&P/ASX 200 | 8,317.10 | 26.60 | -0.32% |
SSE Composite Index | 3,365.88 | 1.58 | -0.05% |